Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

Area of Science:

• Hepatology
• Vascular Medicine
• Gastroenterology

Background:

• Budd Chiari syndrome (BCS) exhibits significant heterogeneity in Asia-Pacific regarding obstruction sites, thrombophilic disorders, and clinical manifestations.
• Common presentations include hepatic vein ostial stenosis, short segment thrombosis, membranous obstruction of the vena cava, and complete hepatic vein thrombosis.

Purpose of the Study:

• To provide clinical guidelines for managing Budd Chiari syndrome (BCS) in the Asia-Pacific region.
• To address the diagnostic and therapeutic challenges posed by the heterogeneity of BCS in this region.

Main Methods:

• Development of clinical guidelines by the Asia Pacific Association for Study of Liver.
• Consideration of regional variations in BCS presentation and underlying thrombophilic disorders.
• Focus on unique therapeutic opportunities for restoring hepatic outflow.

Main Results:

• Guidelines address the diverse etiologies and presentations of BCS across the Asia-Pacific.
• Management strategies consider specific regional patterns of venous obstruction.
• Emphasis on interventional procedures like hepatic vein recanalization and vena cava stenting.

Conclusions:

• Standardized guidelines are crucial for managing the diverse spectrum of Budd Chiari syndrome in the Asia-Pacific.
• Addressing regional heterogeneity in BCS is key to optimizing patient outcomes.
• The guidelines aim to standardize evaluation and management approaches for clinicians.